Forum Financial Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$408K Hold
1,890
0.01% 235
2026
Q1
$346K Sell
1,890
-3,997
-68% -$736K ﹤0.01% 245
2025
Q4
$1.04M Buy
5,887
+3,039
+107% +$496K 0.01% 244
2025
Q3
$399K Buy
2,848
+1
+0% +$135 0.01% 575
2025
Q2
$358K Sell
2,847
-693
-20% -$86.3K 0.01% 566
2025
Q1
$484K Sell
3,540
-264
-7% -$37.7K 0.01% 386
2024
Q4
$582K Buy
3,804
+796
+26% +$134K 0.01% 324
2024
Q3
$583K Buy
3,008
+1
+0% +$209 0.01% 287
2024
Q2
$697K Buy
3,007
+1
+0% +$217 0.01% 227
2024
Q1
$648K Sell
3,006
-37
-1% -$8.66K 0.01% 261
2023
Q4
$787K Hold
3,043
0.01% 198
2023
Q3
$782K Buy
3,043
+1
+0% +$267 0.02% 189
2023
Q2
$867K Hold
3,042
0.02% 180
2023
Q1
$846K Buy
3,042
+43
+1% +$11.9K 0.02% 162
2022
Q4
$830K Sell
2,999
-1,102
-27% -$311K 0.03% 164
2022
Q3
$1.09M Buy
4,101
+708
+21% +$150K 0.05% 107
2022
Q2
$692K Sell
3,393
-382
-10% -$78.1K 0.03% 173
2022
Q1
$795K Buy
3,775
+2,468
+189% +$537K 0.04% 161
2021
Q4
$314K Buy
+1,307
New +$336K 0.02% 395

Other funds holding BIIB

Forum Financial Management's BIIB Position: Q2 2026 in Review

Forum Financial Management held its Biogen (BIIB) position steady in Q2 2026 at 1,890 shares worth $408K. The position accounts for 0.01% of the portfolio, ranked #235.

Forum Financial Management first reported a position in BIIB in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.09M in Q3 2022. 1,038 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Forum Financial Management held 1,890 shares of Biogen worth $408K as of Q2 2026.
  • Forum Financial Management left its Biogen share count unchanged in Q2 2026.
  • Biogen made up 0.01% of Forum Financial Management's portfolio in Q2 2026, its #235 holding.
  • Forum Financial Management first reported a position in Biogen in Q4 2021 and has held it in 19 quarters since.
  • Forum Financial Management's Biogen position peaked at $1.09M in Q3 2022.
  • 1,038 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Forum Financial Management's 13F filing for Q2 2026, filed 23 Jul 2026.